Abstract
In humans, the typical range of the resting sinus heart rate is 50–90 beats per minute (bpm); most average healthy individuals have resting rates in the 60–70 bpm range. Bradycardia (slow heart beat) is a term used to refer to any heart rate <60 bpm, and tachycardia (fast heart beat) indicates rates >100 bpm. Disturbances of cardiac impulse formation and/or transmission comprise the principal mechanisms causing abnormalities of heart rhythm. In basic terms, these are classified as being either brady- or tachy-arrhythmias. The primary goals for treatment of arrhythmias are: (1) to alleviate symptoms and thus improve an individual’s quality of life; and (2) to prolong patient survival. Pharmacologic treatment has been the mainstay for management of most cardiac arrhythmias, although in recent years, implantable devices and ablations have become increasingly important. Therefore, nonpharmacologic therapies have begun to play an increasingly important role in curing many arrhythmias (catheter ablation), and preventing their life-threatening consequences [implantable cardioverter defibrillator (ICD) therapy for both primary and secondary prevention of sudden cardiac death (SCD)].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AFib:
-
Atrial fibrillation
- AT:
-
Atrial tachycardia
- AV:
-
Atrioventricular
- AVNRT:
-
Atrioventricular nodal reentry tachycardia
- AVRT:
-
Atrioventricular reentry tachycardia
- Bpm:
-
Beats per minute
- CFAE:
-
Complex fractionated atrial electrogram
- DC:
-
Direct current
- ECG:
-
Electrocardiography
- EPS:
-
Electrophysiologic study
- ICD:
-
Implantable cardioverter defibrillator
- IST:
-
Inappropriate sinus tachycardia
- LV:
-
Left ventricular
- PAC:
-
Premature atrial complex
- PSVT:
-
Paroxysmal supraventricular tachycardia
- PVC:
-
Premature ventricular complex
- RF:
-
Radiofrequency
- RV:
-
Right ventricular
- SCD:
-
Sudden cardiac death
- SND:
-
Sinus node dysfunction
- SVT:
-
Supraventricular tachycardia
- TdP:
-
Torsades de Pointes
- VT:
-
Ventricular tachycardia
- WPW:
-
Wolff–Parkinson–White syndrome
References
Task Force of the Working Group on Arrhythmias of the European Society of Cardiology (1991) The Sicilian Gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 84:1831–1851
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406–412
The Cardiac Arrhythmia Suppression Trial II Investigators (1992) Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 327:227–233
Josephson ME (ed) (1993) Clinical cardiac electrophysiology. Techniques and interpretations, 2nd edn. Lea & Febiger, Malvern, PA
Benditt DG, Lu F (2006) Atriofascicular pathways: fuzzy nomenclature or merely wishful thinking? J Cardiovasc Electrophysiol 17:261–265
January CT, Wann LS, Alpert JS et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 64:2246–2280
Estes NA 3rd, Halperin JL, Calkins H et al (2008) 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement. J Am Coll Cardiol 51:865–884
Zipes DP, Camm AJ, Borggrefe M et al (2006) 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 48:e247–e346
Stevenson WG, Friedman PL, Kocovic D, Sager PT, Saxon LA, Pavri B (1998) Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 98:308–314
Nabar A, Rodriguez LM, Timmermans C, Smeets JL, Wellens HJ (1999) Isoproterenol to evaluate resumption of conduction after right atrial isthmus ablation in type I atrial flutter. Circulation 99:3286–3291
Oral H, Sticherling C, Tada H et al (2001) Role of transisthmus intervals in predicting bidirectional block after ablation of typical atrial flutter. J Cardiovasc Electrophysiol 12:169–217
Calkins H, Kuck KH, Cappato R et al (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 9:632–696
Stavrakis S, Garabelli P, Reynolds DW (2012) Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace 14:1490–1497
Haissaguerre M, Jais P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666
Chen SA, Tai CT, Tsai CF, Hsieh MH, Ding YA, Chang MS (2000) Radiofrequency catheter ablation of atrial fibrillation initiated by pulmonary vein ectopic beats. J Cardiovasc Electrophysiol 11:218–227
Haissaguerre M, Shah DC, Jais P et al (2000) Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 102:2463–2465
Pappone C, Rosanio S, Oreto G et al (2000) Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 102:2619–2628
Oral H, Scharf C, Chugh A et al (2003) Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 108:2355–2360
Pappone C, Manguso F, Vicedomini G et al (2004) Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach. Circulation 110:3036–3042
Nademanee K, McKenzie J, Kosar E et al (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43:2044–2053
Nademanee K, Schwab M, Porath J, Abbo A (2006) How to perform electrogram-guided atrial fibrillation ablation. Heart Rhythm 3:981–984
Pappone C, Santinelli V, Manguso F et al (2004) Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109:327–334
Packer DL, Kowal RC, Wheelan KR et al (2013) Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 61:1713–1723
Morady F (1999) Radio-frequency ablation as treatment for cardiac arrhythmias. N Engl J Med 340:534–544
Zipes DP (1997) Specific arrhythmias: diagnosis and treatment. In: Braunwald E (ed) Heart disease: a text book of cardiovascular medicine, 5th edn. W.B. Saunders Company, Philadelphia, pp 640–704
Triedman J, Perry J, Van Hare G (2005) Risk stratification for prophylactic ablation in asymptomatic Wolff–Parkinson–White syndrome. N Engl J Med 352:92–93
Stevenson WG, Friedman PL (2000) Catheter ablation of ventricular tachycardia. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology from cell to bedside, 3rd edn. W.B. Saunders Company, Philadelphia, pp 1049–1056
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Roukoz, H., Lü, F., Sakaguchi, S. (2015). Catheter Ablation of Cardiac Arrhythmias. In: Iaizzo, P. (eds) Handbook of Cardiac Anatomy, Physiology, and Devices. Springer, Cham. https://doi.org/10.1007/978-3-319-19464-6_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-19464-6_28
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19463-9
Online ISBN: 978-3-319-19464-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)